1. Home
  2. PGEN vs CUB Comparison

PGEN vs CUB Comparison

Compare PGEN & CUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • CUB
  • Stock Information
  • Founded
  • PGEN 1998
  • CUB 2024
  • Country
  • PGEN United States
  • CUB United States
  • Employees
  • PGEN N/A
  • CUB N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • CUB
  • Sector
  • PGEN Health Care
  • CUB
  • Exchange
  • PGEN Nasdaq
  • CUB NYSE
  • Market Cap
  • PGEN 292.6M
  • CUB 307.3M
  • IPO Year
  • PGEN N/A
  • CUB 2024
  • Fundamental
  • Price
  • PGEN $0.74
  • CUB $10.09
  • Analyst Decision
  • PGEN Buy
  • CUB
  • Analyst Count
  • PGEN 5
  • CUB 0
  • Target Price
  • PGEN $7.00
  • CUB N/A
  • AVG Volume (30 Days)
  • PGEN 1.1M
  • CUB 61.4K
  • Earning Date
  • PGEN 11-14-2024
  • CUB 01-01-0001
  • Dividend Yield
  • PGEN N/A
  • CUB N/A
  • EPS Growth
  • PGEN N/A
  • CUB N/A
  • EPS
  • PGEN N/A
  • CUB N/A
  • Revenue
  • PGEN $3,963,000.00
  • CUB N/A
  • Revenue This Year
  • PGEN N/A
  • CUB N/A
  • Revenue Next Year
  • PGEN $402.12
  • CUB N/A
  • P/E Ratio
  • PGEN N/A
  • CUB N/A
  • Revenue Growth
  • PGEN N/A
  • CUB N/A
  • 52 Week Low
  • PGEN $0.65
  • CUB $9.96
  • 52 Week High
  • PGEN $1.93
  • CUB $10.55
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 46.11
  • CUB N/A
  • Support Level
  • PGEN $0.71
  • CUB N/A
  • Resistance Level
  • PGEN $0.78
  • CUB N/A
  • Average True Range (ATR)
  • PGEN 0.05
  • CUB 0.00
  • MACD
  • PGEN 0.01
  • CUB 0.00
  • Stochastic Oscillator
  • PGEN 61.00
  • CUB 0.00

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About CUB LIONHEART HOLDINGS

Lionheart Holdings is a blank check company.

Share on Social Networks: